Glenmark Pharmaceuticals has announced the upcoming launch of Sodium Phosphates Injection USP in multiple single-dose vial presentations, further strengthening its institutional product portfolio in the North American market. The company will introduce Sodium Phosphates Injection USP in 15 mM P/5 mL, 45 mM P/15 mL and 150 mM P/50 mL (3 mM P/mL) single-dose vials, […]